* Novartis receives three FDA breakthrough therapy
designations for Ilaris to treat rare types of periodic fever
syndromes
The post BRIEF-Novartis receives three FDA breakthrough therapy designations for Ilaris appeared first on NASDAQ.
BRIEF-Novartis receives three FDA breakthrough therapy designations for Ilaris
